vs
CUMBERLAND PHARMACEUTICALS INC（CPIX）与First Bancorp, Inc（FNLC）财务数据对比。点击上方公司名可切换其他公司
First Bancorp, Inc的季度营收约是CUMBERLAND PHARMACEUTICALS INC的1.9倍（$25.8M vs $13.7M），First Bancorp, Inc净利率更高（39.4% vs -10.3%，领先49.7%），CUMBERLAND PHARMACEUTICALS INC同比增速更快（31.1% vs 17.5%），First Bancorp, Inc自由现金流更多（$34.6M vs $3.0K），过去两年CUMBERLAND PHARMACEUTICALS INC的营收复合增速更高（26.9% vs 18.1%）
坎伯兰制药是一家专科制药企业，专注于开发、生产和商业化品牌处方药物，核心产品覆盖急症护理、胃肠病、疼痛管理及罕见病治疗领域，主要运营市场为美国，为相关医护人员与患者提供服务。
第一银行公司（First Bancorp, Inc）是一家银行控股公司，其核心业务通过总部位于康涅狄格州斯坦福的爱国者国家银行（Patriot Bank NA）开展，相关 banking 业务也以PNBK代码在纳斯达克挂牌交易。
CPIX vs FNLC — 直观对比
营收规模更大
FNLC
是对方的1.9倍
$13.7M
营收增速更快
CPIX
高出13.5%
17.5%
净利率更高
FNLC
高出49.7%
-10.3%
自由现金流更多
FNLC
多$34.6M
$3.0K
两年增速更快
CPIX
近两年复合增速
18.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.7M | $25.8M |
| 净利润 | $-1.4M | $10.2M |
| 毛利率 | 83.6% | — |
| 营业利润率 | -10.0% | 48.1% |
| 净利率 | -10.3% | 39.4% |
| 营收同比 | 31.1% | 17.5% |
| 净利润同比 | 25.8% | 39.7% |
| 每股收益（稀释后） | $-0.09 | $0.91 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CPIXFNLC
| Q4 25 | $13.7M | $25.8M | ||
| Q3 25 | $8.3M | $24.5M | ||
| Q2 25 | $10.8M | $22.5M | ||
| Q1 25 | $11.7M | $21.8M | ||
| Q4 24 | $10.4M | $22.0M | ||
| Q3 24 | $9.1M | $20.5M | ||
| Q2 24 | $9.8M | $19.2M | ||
| Q1 24 | $8.5M | $18.5M |
净利润CPIXFNLC
| Q4 25 | $-1.4M | $10.2M | ||
| Q3 25 | $-1.9M | $9.1M | ||
| Q2 25 | $-740.7K | $8.1M | ||
| Q1 25 | $1.3M | $7.1M | ||
| Q4 24 | $-1.9M | $7.3M | ||
| Q3 24 | $-1.5M | $7.6M | ||
| Q2 24 | $-1.1M | $6.2M | ||
| Q1 24 | $-1.9M | $6.0M |
毛利率CPIXFNLC
| Q4 25 | 83.6% | — | ||
| Q3 25 | 88.1% | — | ||
| Q2 25 | 81.4% | — | ||
| Q1 25 | 87.8% | — | ||
| Q4 24 | 81.1% | — | ||
| Q3 24 | 85.4% | — | ||
| Q2 24 | 82.6% | — | ||
| Q1 24 | 81.5% | — |
营业利润率CPIXFNLC
| Q4 25 | -10.0% | 48.1% | ||
| Q3 25 | -23.7% | 45.2% | ||
| Q2 25 | -6.9% | 43.7% | ||
| Q1 25 | 11.0% | 39.3% | ||
| Q4 24 | -17.7% | 39.5% | ||
| Q3 24 | -18.6% | 44.6% | ||
| Q2 24 | -10.4% | 38.8% | ||
| Q1 24 | -22.0% | 39.3% |
净利率CPIXFNLC
| Q4 25 | -10.3% | 39.4% | ||
| Q3 25 | -23.4% | 37.0% | ||
| Q2 25 | -6.8% | 35.8% | ||
| Q1 25 | 10.7% | 32.5% | ||
| Q4 24 | -18.2% | 33.1% | ||
| Q3 24 | -17.0% | 36.9% | ||
| Q2 24 | -11.0% | 32.1% | ||
| Q1 24 | -22.9% | 32.5% |
每股收益（稀释后）CPIXFNLC
| Q4 25 | $-0.09 | $0.91 | ||
| Q3 25 | $-0.13 | $0.81 | ||
| Q2 25 | $-0.05 | $0.72 | ||
| Q1 25 | $0.08 | $0.63 | ||
| Q4 24 | $-0.13 | $0.66 | ||
| Q3 24 | $-0.11 | $0.68 | ||
| Q2 24 | $-0.08 | $0.55 | ||
| Q1 24 | $-0.14 | $0.54 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.4M | — |
| 总债务越低越好 | — | $95.5M |
| 股东权益账面价值 | $24.9M | $283.1M |
| 总资产 | $76.8M | $3.2B |
| 负债/权益比越低杠杆越低 | — | 0.34× |
8季度趋势，按日历期对齐
现金及短期投资CPIXFNLC
| Q4 25 | $11.4M | — | ||
| Q3 25 | $15.2M | — | ||
| Q2 25 | $16.1M | — | ||
| Q1 25 | $15.1M | — | ||
| Q4 24 | $18.0M | — | ||
| Q3 24 | $17.5M | — | ||
| Q2 24 | $17.3M | — | ||
| Q1 24 | $18.5M | — |
总债务CPIXFNLC
| Q4 25 | — | $95.5M | ||
| Q3 25 | — | $95.5M | ||
| Q2 25 | — | $95.0M | ||
| Q1 25 | — | $70.0M | ||
| Q4 24 | — | $95.0M | ||
| Q3 24 | — | $95.0M | ||
| Q2 24 | — | $70.0M | ||
| Q1 24 | — | $70.0M |
股东权益CPIXFNLC
| Q4 25 | $24.9M | $283.1M | ||
| Q3 25 | $26.1M | $274.6M | ||
| Q2 25 | $28.0M | $265.5M | ||
| Q1 25 | $28.7M | $259.7M | ||
| Q4 24 | $22.9M | $252.5M | ||
| Q3 24 | $24.8M | $256.8M | ||
| Q2 24 | $26.3M | $244.7M | ||
| Q1 24 | $27.5M | $242.6M |
总资产CPIXFNLC
| Q4 25 | $76.8M | $3.2B | ||
| Q3 25 | $65.9M | $3.2B | ||
| Q2 25 | $67.9M | $3.2B | ||
| Q1 25 | $69.9M | $3.2B | ||
| Q4 24 | $75.6M | $3.2B | ||
| Q3 24 | $76.7M | $3.1B | ||
| Q2 24 | $78.5M | $3.1B | ||
| Q1 24 | $81.5M | $3.0B |
负债/权益比CPIXFNLC
| Q4 25 | — | 0.34× | ||
| Q3 25 | — | 0.35× | ||
| Q2 25 | — | 0.36× | ||
| Q1 25 | — | 0.27× | ||
| Q4 24 | — | 0.38× | ||
| Q3 24 | — | 0.37× | ||
| Q2 24 | — | 0.29× | ||
| Q1 24 | — | 0.29× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.0K | $37.8M |
| 自由现金流经营现金流 - 资本支出 | $3.0K | $34.6M |
| 自由现金流率自由现金流/营收 | 0.0% | 133.9% |
| 资本支出强度资本支出/营收 | 0.0% | 12.5% |
| 现金转化率经营现金流/净利润 | — | 3.72× |
| 过去12个月自由现金流最近4个季度 | $4.8M | $55.3M |
8季度趋势，按日历期对齐
经营现金流CPIXFNLC
| Q4 25 | $3.0K | $37.8M | ||
| Q3 25 | $187.2K | $12.9M | ||
| Q2 25 | $843.8K | $7.4M | ||
| Q1 25 | $3.9M | $2.2M | ||
| Q4 24 | $1.9M | $26.0M | ||
| Q3 24 | $475.5K | $9.8M | ||
| Q2 24 | $-855.7K | $6.4M | ||
| Q1 24 | $-2.1M | $-1.5M |
自由现金流CPIXFNLC
| Q4 25 | $3.0K | $34.6M | ||
| Q3 25 | $163.4K | $12.6M | ||
| Q2 25 | $817.3K | $7.2M | ||
| Q1 25 | $3.9M | $828.0K | ||
| Q4 24 | $1.9M | $24.6M | ||
| Q3 24 | $460.1K | $9.6M | ||
| Q2 24 | $-862.8K | $6.3M | ||
| Q1 24 | $-2.2M | $-1.8M |
自由现金流率CPIXFNLC
| Q4 25 | 0.0% | 133.9% | ||
| Q3 25 | 2.0% | 51.4% | ||
| Q2 25 | 7.5% | 32.1% | ||
| Q1 25 | 32.9% | 3.8% | ||
| Q4 24 | 18.2% | 111.7% | ||
| Q3 24 | 5.1% | 47.0% | ||
| Q2 24 | -8.8% | 32.9% | ||
| Q1 24 | -25.6% | -9.8% |
资本支出强度CPIXFNLC
| Q4 25 | 0.0% | 12.5% | ||
| Q3 25 | 0.3% | 1.2% | ||
| Q2 25 | 0.2% | 0.6% | ||
| Q1 25 | 0.4% | 6.2% | ||
| Q4 24 | 0.0% | 6.7% | ||
| Q3 24 | 0.2% | 0.5% | ||
| Q2 24 | 0.1% | 0.3% | ||
| Q1 24 | 0.5% | 1.8% |
现金转化率CPIXFNLC
| Q4 25 | — | 3.72× | ||
| Q3 25 | — | 1.42× | ||
| Q2 25 | — | 0.91× | ||
| Q1 25 | 3.10× | 0.31× | ||
| Q4 24 | — | 3.58× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | 1.03× | ||
| Q1 24 | — | -0.25× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
